Try our mobile app

Published: 2023-05-03 00:00:00 ET
<<<  go to WELL company page
well-20230331
0000766704false2023Q1December 31P1Yhttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityP3Y00007667042023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704well:GuaranteeNotesDue20284800Member2023-01-012023-03-310000766704well:GuaranteeNotesDue20344500Member2023-01-012023-03-3100007667042023-04-28xbrli:shares00007667042023-03-31iso4217:USD00007667042022-12-310000766704us-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:ManagementServiceMember2022-01-012022-03-3100007667042022-01-012022-03-310000766704well:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMember2022-01-012022-03-31iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-310000766704us-gaap:CommonStockMember2021-12-310000766704us-gaap:AdditionalPaidInCapitalMember2021-12-310000766704us-gaap:TreasuryStockCommonMember2021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-12-310000766704well:AccumulatedDistributionsMember2021-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000766704us-gaap:NoncontrollingInterestMember2021-12-3100007667042021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-01-012022-03-310000766704us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-01-012022-03-310000766704us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000766704well:AccumulatedDistributionsMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-03-310000766704us-gaap:TreasuryStockCommonMember2022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-03-310000766704well:AccumulatedDistributionsMember2022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000766704us-gaap:NoncontrollingInterestMember2022-03-3100007667042022-03-310000766704well:WelltowerOPIncMember2023-01-012023-03-31xbrli:pure0000766704well:WelltowerOPIncMember2023-03-310000766704well:OtherInvestorsMemberwell:WelltowerOPIncMember2023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2022-01-012022-03-310000766704well:SeniorHousingOperatingMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:SeniorHousingOperatingMember2022-03-310000766704well:TripleNetMember2022-03-310000766704well:OutpatientMedicalMember2022-03-310000766704well:SeniorHousingOperatingMember2023-01-012023-03-310000766704well:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMember2022-01-012022-03-310000766704well:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMember2022-01-012022-03-310000766704well:HolidayRetirementMember2022-04-01well:property00007667042022-04-012022-04-010000766704us-gaap:OtherIncomeMember2022-04-012022-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-03-310000766704us-gaap:LeasesAcquiredInPlaceMember2022-12-310000766704us-gaap:AboveMarketLeasesMember2023-03-310000766704us-gaap:AboveMarketLeasesMember2022-12-310000766704well:LeaseCommissionsMember2023-03-310000766704well:LeaseCommissionsMember2022-12-310000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-03-310000766704srt:MinimumMember2023-01-012023-03-310000766704srt:MaximumMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2022-01-012022-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2023-03-310000766704us-gaap:CorporateNonSegmentMember2022-12-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-03-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2022-12-310000766704us-gaap:MortgageReceivablesMember2023-03-310000766704us-gaap:MortgageReceivablesMember2022-12-310000766704well:OtherRealEstateLoansReceivablesMember2023-03-310000766704well:OtherRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704us-gaap:RealEstateLoanMember2022-12-310000766704well:DeterioratedLoansMember2023-03-31well:loan0000766704well:CollectiveLoanPool1Member2023-03-310000766704well:CollectiveLoanPool2Member2023-03-310000766704well:CollectiveLoanPool3Member2023-03-310000766704well:CollectiveLoanPool4Member2023-03-310000766704well:CollectiveLoanPool5Member2023-03-310000766704well:CollectiveLoanPool6Member2023-03-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MinimumMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2023-03-310000766704well:SeniorsHousingOperatingMember2023-03-310000766704well:SeniorsHousingOperatingMember2022-12-310000766704well:TripleNetMembersrt:MinimumMember2023-03-310000766704well:TripleNetMembersrt:MaximumMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:TripleNetMember2022-12-310000766704well:OutpatientMedicalMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberwell:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2022-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-31well:properties0000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704well:HCOneGroupMember2023-03-31iso4217:GBPwell:bank0000766704us-gaap:RevolvingCreditFacilityMember2023-03-310000766704well:TermCreditFacilityMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMember2023-03-31iso4217:CAD0000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2026Member2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2025Member2023-03-31well:Term0000766704us-gaap:RevolvingCreditFacilityMember2023-01-012023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:AccordionfeaturememberMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMemberwell:AccordionfeaturememberMember2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMembersrt:MaximumMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMember2023-03-310000766704us-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:SecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2023-03-310000766704us-gaap:SecuredDebtMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberus-gaap:SecuredDebtMember2023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-03-31well:term0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-03-310000766704well:UkDebtDue2028Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2023-03-310000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2021-12-310000766704us-gaap:UnsecuredDebtMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMember2022-01-012022-03-310000766704us-gaap:UnsecuredDebtMember2022-03-310000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2021-12-310000766704us-gaap:SecuredDebtMember2023-01-012023-03-310000766704us-gaap:SecuredDebtMember2022-01-012022-03-310000766704us-gaap:SecuredDebtMember2022-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-03-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-12-310000766704currency:USDus-gaap:NondesignatedMember2023-03-310000766704currency:USDus-gaap:NondesignatedMember2022-12-310000766704currency:CADus-gaap:NondesignatedMember2023-03-310000766704currency:CADus-gaap:NondesignatedMember2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000766704us-gaap:NondesignatedMember2023-01-012023-03-310000766704us-gaap:NondesignatedMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-31well:obligation0000766704well:CapitalImprovementsMember2023-03-310000766704well:AtTheMarketProgramMember2022-04-300000766704well:AtTheMarketProgramMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000766704us-gaap:EmployeeStockOptionMember2022-01-012022-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:FairValueInputsLevel1Member2023-03-310000766704us-gaap:FairValueInputsLevel2Member2023-03-310000766704us-gaap:FairValueInputsLevel3Member2023-03-310000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2021-12-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-03-310000766704us-gaap:WarrantMember2022-03-310000766704well:TerminalCapitalizationRateMember2023-03-31well:segment0000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704country:US2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:US2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GB2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GB2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CA2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CA2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:USus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:USus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GBus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CAus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:US2023-03-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:US2022-12-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:GB2023-03-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:GB2022-12-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:CA2023-03-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:CA2022-12-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-03-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
   
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
   
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of April 28, 2023, Welltower Inc. had 497,031,161 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
  
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
  
Consolidated Statements of Comprehensive Income
  
Consolidated Statements of Equity
  
Consolidated Statements of Cash Flows
  
Notes to Unaudited Consolidated Financial Statements
  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
Item 4. Controls and Procedures
  
PART II. OTHER INFORMATION 
  
Item 1. Legal Proceedings
  
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 5. Other Information
  
Item 6. Exhibits
  
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
March 31, 2023 (Unaudited)December 31, 2022 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,324,541 $4,249,834 
Buildings and improvements  34,161,466 33,651,336 
Acquired lease intangibles  1,990,830 1,945,458 
Real property held for sale, net of accumulated depreciation  215,583 133,058 
Construction in progress  1,121,446 1,021,080 
Less accumulated depreciation and amortization  (8,417,151)(8,075,733)
Net real property owned  33,396,715 32,925,033 
Right of use assets, net322,896 323,942 
Real estate loans receivable, net of credit allowance  954,156 890,844 
Net real estate investments  34,673,767 34,139,819 
Other assets:  
Investments in unconsolidated entities  1,596,413 1,499,790 
Goodwill  68,321 68,321 
Cash and cash equivalents  571,902 631,681 
Restricted cash  66,894 90,611 
Straight-line rent receivable357,359 322,173 
Receivables and other assets  1,159,233 1,140,838 
Total other assets  3,820,122 3,753,414 
Total assets  
$38,493,889 $37,893,233 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  12,486,229 12,437,273 
Secured debt  2,474,837 2,110,815 
Lease liabilities415,169 415,824 
Accrued expenses and other liabilities  1,521,499 1,535,325 
Total liabilities  
16,897,734 16,499,237 
Redeemable noncontrolling interests  
392,195 384,443 
Equity:  
Common stock  497,928 491,919 
Capital in excess of par value  27,160,014 26,742,750 
Treasury stock  (112,925)(111,001)
Cumulative net income  8,830,623 8,804,950 
Cumulative dividends  (15,815,926)(15,514,097)
Accumulated other comprehensive income (loss)  (111,559)(119,707)
Total Welltower Inc. stockholders’ equity  20,448,155 20,294,814 
Noncontrolling interests  755,805 714,739 
Total equity  
21,203,960 21,009,553 
Total liabilities and equity  
$38,493,889 $37,893,233 
Note: The consolidated balance sheet at December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months Ended
March 31,
 20232022
Revenues:  
Resident fees and services$1,131,685 $994,335 
Rental income  384,059 356,390 
Interest income36,405 38,994 
Other income8,580 5,985 
Total revenues1,560,729 1,395,704 
Expenses:
Property operating expenses957,753 853,669 
Depreciation and amortization339,112 304,088 
Interest expense144,403 121,696 
General and administrative expenses44,371 37,706 
Loss (gain) on derivatives and financial instruments, net930 2,578 
Loss (gain) on extinguishment of debt, net5 (12)
Provision for loan losses, net777 (804)
Impairment of assets12,629  
Other expenses22,745 26,069 
Total expenses1,522,725 1,344,990 
Income (loss) from continuing operations before income taxes and other items38,004 50,714 
Income tax (expense) benefit(3,045)(5,013)
Income (loss) from unconsolidated entities(7,071)(2,884)
Gain (loss) on real estate dispositions, net747 22,934 
Income (loss) from continuing operations28,635 65,751 
Net income (loss)28,635 65,751 
Less: Net income (loss) attributable to noncontrolling interests(1)
2,962 3,826 
Net income (loss) attributable to common stockholders$25,673 $61,925 
Weighted average number of common shares outstanding:
Basic492,061 447,379 
Diluted494,494 449,802 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.06 $0.15 
Net income (loss) attributable to common stockholders$0.05 $0.14 
Diluted:
Income (loss) from continuing operations$0.06 $0.15 
Net income (loss) attributable to common stockholders(2)
$0.05 $0.14 
Dividends declared and paid per common share$0.61 $0.61 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months Ended
March 31,
 20232022
Net income (loss)$28,635 $65,751 
Other comprehensive income (loss):
Foreign currency translation gain (loss)80,765 (66,948)
Derivative and financial instruments designated as hedges gain (loss)(69,738)51,940 
Total other comprehensive income (loss)11,027 (15,008)
Total comprehensive income (loss)39,662 50,743 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
5,841 5,974 
Total comprehensive income (loss) attributable to common stockholders$33,821 $44,769 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended March 31, 2023
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)   25,673   2,688 28,361 
Other comprehensive income (loss)     8,148 3,023 11,171 
Total comprehensive income       39,532 
Net change in noncontrolling interests (8,304)    29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP (6,139)    6,139  
Redemption of OP Units and DownREIT Units272 17,515     (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)    7,540 
Net proceeds from issuance of common stock5,603 404,862      410,465 
Dividends paid:
Common stock dividends    (301,829)  (301,829)
Balances at March 31, 2023$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
 Three Months Ended March 31, 2022
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2022$448,605 $23,133,641 $(107,750)$8,663,736 $(14,380,915)$(121,316)$960,578 $18,596,579 
Comprehensive income:
Net income (loss)61,925 2,752 64,677 
Other comprehensive income (loss)(17,156)1,465 (15,691)
Total comprehensive income48,986 
Net change in noncontrolling interests(63,026)(128,305)(191,331)
Amounts related to stock incentive plans, net of forfeitures166 7,279 (4,768)2,677 
Net proceeds from issuance of common stock6,605 542,218 548,823 
Dividends paid:
Common stock dividends(273,668)(273,668)
Balances at March 31, 2022$455,376 $23,620,112 $(112,518)$8,725,661 $(14,654,583)$(138,472)$836,490 $18,732,066 

6


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended
March 31,
 20232022
Operating activities:    
Net income  $28,635 $65,751 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
339,112 304,088 
Other amortization expenses  
9,792 5,592 
Provision for loan losses, net777 (804)
Impairment of assets  
12,629  
Stock-based compensation expense  
9,456 7,445 
Loss (gain) on derivatives and financial instruments, net  
930 2,578 
Loss (gain) on extinguishment of debt, net  
5 (12)
Loss (income) from unconsolidated entities
7,071 2,884 
Rental income less than (in excess of) cash received  
(36,827)(22,215)
Amortization related to above (below) market leases, net  
(82)(419)
Loss (gain) on real estate dispositions, net  
(747)(22,934)
Distributions by unconsolidated entities
3,418 6,982 
Increase (decrease) in accrued expenses and other liabilities  
(4,503)(23,416)
Decrease (increase) in receivables and other assets  
6,392 (1,000)
Net cash provided from (used in) operating activities  376,058 324,520 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(402,719)(601,410)
Cash disbursed for capital improvements to existing properties
(91,339)(90,229)
Cash disbursed for construction in progress
(226,226)(138,141)
Capitalized interest  
(10,335)(5,479)
Investment in loans receivable
(54,831)(39,201)
Principal collected on loans receivable  
15,592 89,207 
Other investments, net of payments  
(80,548)2,401 
Contributions to unconsolidated entities  
(112,822)(115,249)
Distributions by unconsolidated entities  
4,800 5,882 
Proceeds from (payments on) derivatives  
3,933 10,104 
Proceeds from sales of real property  
21,658 73,568 
Net cash provided from (used in) investing activities  (932,837)(808,547)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
 (24,967)
Net proceeds from issuance of senior unsecured notes 545,082 
Net proceeds from the issuance of secured debt  
362,900 5,385 
Payments on secured debt  
(39,573)(116,789)
Net proceeds from the issuance of common stock  
411,032 549,346 
Payments for deferred financing costs and prepayment penalties  
(6,444)(69)
Contributions by noncontrolling interests(1)
83,480 4,101 
Distributions to noncontrolling interests(1)
(35,664)(177,979)
Cash distributions to stockholders  
(300,195)(273,045)
Other financing activities
(5,066)(5,960)
Net cash provided from (used in) financing activities  470,470 505,105 
Effect of foreign currency translation on cash and cash equivalents and restricted cash2,813 (790)
Increase (decrease) in cash, cash equivalents and restricted cash  (83,496)20,288 
Cash, cash equivalents and restricted cash at beginning of period  722,292 346,755 
Cash, cash equivalents and restricted cash at end of period  $638,796 $367,043 
Supplemental cash flow information:
Interest paid$148,399 $123,012 
Income taxes paid (received), net325 631 
(1) Includes amounts attributable to redeemable noncontrolling interests.

7

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower Inc., a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties. 
As of May 24, 2022, we are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.735% for the three months ended March 31, 2023. As of March 31, 2023, Welltower owned 99.721% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.279% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily an indication of the results that may be expected for the year ending December 31, 2023. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Impact of COVID-19 Pandemic & Government Grants
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence. We have received government grants under the CARES Act, as well as under similar programs in the U.K. and Canada, primarily to cover increased expenses and lost revenue during the COVID-19 pandemic. We recognized $4,136,000 and $5,760,000 during the three months ended March 31, 2023 and 2022, respectively. These grants represent a reduction to property operating expenses in our Consolidated Statements of Comprehensive Income. The amount of qualifying expenditures and lost revenue exceeded grant income recognized and we believe we have complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts are subject to recapture.
New Accounting Standards   
In March 2020, the FASB issued an amendment to the reference rate reform standard, which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. In December 2022, the FASB extended the date for which this guidance can be applied from December 31, 2022 to December 31, 2024. We continue to monitor developments related to the LIBOR transition and identification of an alternative, market-accepted rate.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
8

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$2,517 $7,370 $60,527 $70,414 $43,897 $ $240 $44,137 
Buildings and improvements16,434 74,289 255,706 346,429 402,342 171 131,412 533,925 
Acquired lease intangibles865  39,090 39,955 31,366  16,978 48,344 
Right of use assets, net  927 927   3,852 3,852 
Total net real estate assets19,816 81,659 356,250 457,725 477,605 171 152,482 630,258 
Receivables and other assets234  358 592 1,630   1,630 
Total assets acquired20,050 81,659 356,608 458,317 479,235 171 152,482 631,888 
Secured debt(5,501) (40,953)(46,454)    
Lease liabilities  (953)(953)  (3,852)(3,852)
Accrued expenses and other liabilities(120) (8,071)(8,191)(4,154)  (4,154)
Total liabilities acquired(5,621) (49,977)(55,598)(4,154) (3,852)(8,006)
Noncontrolling interests (1)
    (20,348)(4) (20,352)
Non-cash acquisition related activity(2)
    (2,120)  (2,120)
Cash disbursed for acquisitions14,429 81,659 306,631 402,719 452,613 167 148,630 601,410 
Construction in progress additions131,944 4,995 101,609 238,548 113,407 20,756 9,642 143,805 
Less: Capitalized interest(7,950)(1,248)(1,137)(10,335)(4,179)(1,089)(211)(5,479)
Accruals (3)
2,303  (4,290)(1,987)(1,963) 1,778 (185)
Cash disbursed for construction in progress126,297 3,747 96,182 226,226 107,265 19,667 11,209 138,141 
Capital improvements to existing properties69,783 4,427 17,129 91,339 68,612 8,294 13,323 90,229 
Total cash invested in real property, net of cash acquired$210,509 $89,833 $419,942 $720,284 $628,490 $28,128 $173,162 $829,780 
(1) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests.
(2) Relates to the acquisition of assets recognized as investments in unconsolidated entities.
(3) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Development projects:
Seniors Housing Operating
$26,712 $73,458 
Outpatient Medical
9,351  
Total development projects
36,063 73,458 
Expansion projects
17,245  
Total construction in progress conversions$53,308 $73,458 


9

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 March 31, 2023December 31, 2022
Assets:
In place lease intangibles$1,846,945 $1,817,580 
Above market tenant leases66,354 57,203 
Lease commissions77,531 70,675 
Gross historical cost1,990,830 1,945,458 
Accumulated amortization(1,543,457)(1,484,048)
Net book value$447,373 $461,410 
Liabilities:
Below market tenant leases$82,084 $77,985 
Accumulated amortization(54,872)(52,701)
Net book value$27,212 $25,284 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended March 31,
20232022
Rental income related to (above)/below market tenant leases, net$45 $385 
Amortization related to in place lease intangibles and lease commissions(56,151)(47,994)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At March 31, 2023, five Seniors Housing Operating properties, seven Triple-net properties and one Outpatient Medical property with an aggregate real estate balance of $215,583,000 were classified as held for sale. In addition to the real property balances, lease liabilities of $66,530,000 and net other assets and (liabilities) of $6,095,000 are included in the Consolidated Balance Sheets related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties are approximately $292,623,000.
During the three months ended March 31, 2023, we recorded $12,629,000 of impairment charges related to three Seniors Housing Operating properties classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value. We did not record any impairment charges during the three months ended March 31, 2022.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Real estate dispositions:
Seniors Housing Operating
$18,572 $ 
Triple-net
2,028 52,661 
Total dispositions
20,600 52,661 
Gain (loss) on real estate dispositions, net747 22,934 
Net other assets/(liabilities) disposed311 (2,027)
Proceeds from real estate dispositions$21,658 $73,568 
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of March 31, 2023 of $(11,733,000) and $1,337,000 for the three month periods ended March 31, 2023 and 2022, respectively.


10

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the periods presented (in thousands):
Three Months Ended
 ClassificationMarch 31, 2023March 31, 2022
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$5,520 $5,816 
Non-real estate investment lease expenseGeneral and administrative expenses1,863 978 
Finance lease cost:
Amortization of leased assetsProperty operating expenses2,284 1,156 
Interest on lease liabilitiesInterest expense1,427 1,618 
Sublease incomeRental income(2,950)(2,715)
Total $8,144 $6,853 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationMarch 31, 2023December 31, 2022
Right of use assets:
Operating leases - real estateRight of use assets, net$287,275 $287,984 
Finance leases - real estateRight of use assets, net35,621 35,958 
Real estate right of use assets, net322,896 323,942 
Operating leases - non-real estate investmentsReceivables and other assets9,281 10,119 
Finance leases - held for sale (1)
Real property held for sale, net of accumulated depreciation115,359 116,453 
Total right of use assets, net$447,536 $450,514 
Lease liabilities:
Operating leases$301,915 $302,360 
Financing leases113,254 113,464 
Total$415,169 $415,824 
(1) At March 31, 2023, finance leases at seven properties were classified as held for sale.
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. 
Leases in our Triple-net and Outpatient Medical portfolios recognized under ASC 842, "Leases" (ASC 842), typically include some form of operating expense reimbursement by the tenant. For the three months ended March 31, 2023, we recognized $384,059,000 of rental income related to operating leases, of which $53,794,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the three months ended March 31, 2022, we recognized $356,390,000 of rental income related to operating leases, of which $48,074,000 was for variable lease payments.
For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $108,915,000 and $94,827,000 for the three months ended March 31, 2023 and 2022, respectively.



11

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets. Real estate loans receivable consists of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, as well as corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $24,556,000 and $22,878,000 as of March 31, 2023 and December 31, 2022, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):
 March 31, 2023December 31, 2022
Mortgage loans$728,796 $707,464 
Other real estate loans238,400 195,566 
Allowance for credit losses on real estate loans receivable(13,040)(12,186)
Real estate loans receivable, net of credit allowance954,156 890,844 
Non-real estate loans468,791 441,231 
Allowance for credit losses on non-real estate loans receivable(171,278)(152,063)
Non-real estate loans receivable, net of credit allowance297,513 289,168 
Total loans receivable, net of credit allowance$1,251,669 $1,180,012 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Three Months Ended
 March 31, 2023March 31, 2022
Advances on loans receivable$54,831 $39,201 
Less: Receipts on loans receivable15,592 89,207 
Net cash advances (receipts) on loans receivable$39,239 $(50,006)
The allowance for credit losses on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality, we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. No interest was recognized on deteriorated loans for the periods presented.
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
March 31, 2023
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2023$193,918 $(167,515)$26,403 4 
Collective loan pool2007 - 2018211,004 (2,866)208,138 12 
Collective loan pool201923,333 (317)23,016 4 
Collective loan pool202043,067 (585)42,482 6 
Collective loan pool2021777,173 (10,493)766,680 18 
Collective loan pool2022135,004 (1,833)133,171 29 
Collective loan pool202352,488 (709)51,779 3 
Total loans$1,435,987 $(184,318)$1,251,669 76 
12

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The total allowance for credit losses balance is deemed sufficient to absorb expected losses relating to our loan portfolio. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                            
Three Months Ended
March 31, 2023March 31, 2022
Balance at beginning of period$164,249 $166,785 
Provision for loan losses, net777 (804)
Purchased deteriorated loan19,077  
Foreign currency translation215 (288)
Balance at end of period$184,318 $165,693 
8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. Our share of the results of operations for these properties has been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 
 
Percentage Ownership (1)
March 31, 2023December 31, 2022
Seniors Housing Operating
10% to 65%
$1,232,487 $1,171,307 
Triple-net
10% to 88%
138,852 111,812 
Outpatient Medical
15% to 50%
225,074 216,671 
Total $1,596,413 $1,499,790 
(1) As of March 31, 2023 and includes ownership of investments classified as liabilities and excludes ownership of in substance real estate.
At March 31, 2023, the aggregate unamortized basis difference of our joint venture investments of $143,616,000 is primarily attributable to the difference between the amount for which we purchased our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.
We have made loans related to 22 properties as of March 31, 2023 for the development and construction of certain properties which are classified as in substance real estate investments and have a carrying value of $713,342,000. We believe that such borrowers typically represent variable interest entities ("VIE" or "VIEs") in accordance with ASC 810, "Consolidation." VIEs are required to be consolidated by their primary beneficiary which is the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. We have concluded that we are not the primary beneficiary of such borrowers, therefore, the loan arrangements were assessed based on among other factors, the amount and timing of expected residual profits, the estimated fair value of the collateral and the significance of the borrower's equity in the project. Based on these assessments, the arrangements have been classified as in substance real estate investments. We expect to fund an additional $140,641,000 related to these investments.
9. Credit Concentration
We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the three months ended March 31, 2023, excluding our share of NOI in unconsolidated entities (dollars in thousands):
Concentration by relationship: (1)
Number of PropertiesTotal NOI
Percent of NOI (2)
Integra Healthcare Properties
147 $53,885 9%
Sunrise Senior Living109 36,885 6%
Cogir Management Corporation48 21,911 4%
StoryPoint Senior Living74 21,769 4%
HC-One Group (3)
1 20,389 3%
Remaining portfolio1,406 448,137 74%
Totals1,785 $602,976 100%
(1) Integra Healthcare Properties and HC-One Group are in our Triple-net segment. Sunrise Senior Living and Cogir Management Corporation are in our Seniors Housing Operating segment. StoryPoint Senior Living operates assets in both our Seniors Housing Operating and Triple-net segments.
(2) NOI with our top five relationships comprised 30% of total NOI for the year ended December 31, 2022.
(3) In addition to the one property, HC-One Group is the borrower on a £520,854,000 loan as of March 31, 2023, which is included in NOI.
13

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

10. Borrowings Under Credit Facilities and Commercial Paper Program 
At March 31, 2023, we had a primary unsecured credit facility with a consortium of 31 banks that included a $4,000,000,000 unsecured revolving credit facility, a $1,000,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. The unsecured revolving credit facility is comprised of a $1,000,000,000 tranche that matures on June 4, 2026 (none outstanding at March 31, 2023) and a $3,000,000,000 tranche that matures on June 4, 2025 (none outstanding at March 31, 2023). The term credit facilities mature on July 19, 2026. Each tranche of the revolving facility and term loans may be extended for two successive terms of six months at our option. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $1,000,000,000 unsecured term credit facility by up to an additional $1,250,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at March 31, 2023). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over the secured overnight financing rate ("SOFR") interest rate. Based on our current credit ratings, the loans under the unsecured revolving credit facility currently bear interest at 0.775% over the adjusted SOFR rate at March 31, 2023. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at March 31, 2023. 
Under the terms of our commercial paper program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000 (none outstanding at March 31, 2023).
The following information relates to aggregate borrowings under the unsecured revolving credit facility and commercial paper program for the periods presented (dollars in thousands):
Three Months Ended March 31,
20232022
Balance outstanding at quarter end$$300,000
Maximum amount outstanding at any month end$205,000$995,660
Average amount outstanding (total of daily principal balances divided by days in period)$65,833$961,463
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)5.05 %0.53 %
 
11. Senior Unsecured Notes and Secured Debt 
We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of: (i) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (ii) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. At March 31, 2023, the annual principal payments due on these debt obligations were as follows (in thousands):
Senior
Unsecured Notes (1,2,3)
Secured
Debt (1,4)
Totals
2023$ $550,304 $550,304 
20241,350,000 376,620 1,726,620 
20251,260,000 287,203 1,547,203 
2026700,000 139,870 839,870 
2027 (5, 6)
1,906,654 186,449 2,093,103 
Thereafter (7, 8)
7,398,745 966,362 8,365,107 
Totals$12,615,399 $2,506,808 $15,122,207 
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheets.
(2) Annual interest rates range from 2.05% to 6.50%.
(3) All senior unsecured notes with the exception of the $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued by Welltower OP and are fully and unconditionally guaranteed by Welltower. The $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued through private placement by a wholly owned subsidiary of Welltower OP and are fully and unconditionally guaranteed by Welltower OP.
(4) Annual interest rates range from 1.25% to 7.75%. Gross real property value of the properties securing the debt totaled $5,800,377,000 at March 31, 2023.

14

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(5) Includes a $1,000,000,000 unsecured term loan and a $250,000,000 Canadian-denominated unsecured term loan (approximately $184,843,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2023). Both term loans mature on July 19, 2026 and may be extended for two successive terms of six months at our option. The loans bear interest at adjusted SOFR plus 0.85% (5.78% at March 31, 2023) and Canadian Dealer Offered Rate plus 0.85% (5.79% at March 31, 2023), respectively.
(6) Includes a $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 (approximately $221,811,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2023).
(7) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $680,295,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on March 31, 2023).
(8) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $618,450,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on March 31, 2023).
Welltower, the parent entity that consolidates Welltower OP and all other subsidiaries, fully and unconditionally guarantees to each holder of all series of senior unsecured notes issued by Welltower OP that the principal of and premium, if any, and interest on the notes will be promptly paid in full when due, whether at the applicable maturity date, by acceleration or redemption or otherwise, and interest on the overdue principal of and interest on the notes, if any, if lawful, and all other obligations of Welltower OP to the holders of the notes will be promptly paid in full or performed. Welltower’s guarantees of such notes are its senior unsecured obligation and rank equally with all of Welltower’s other future unsecured senior indebtedness and guarantees from time to time outstanding. Welltower’s guarantees of such notes are effectively subordinated to all liabilities of its subsidiaries and to its secured indebtedness to the extent of the assets securing such indebtedness. Because Welltower conducts substantially all of its business through its subsidiaries, Welltower's ability to make required payments with respect to the guarantees depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries, whether by dividends, loans, distributions or other payments.
The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$12,584,529 4.06%$11,707,961 3.67%
Debt issued %550,000 3.85%
Foreign currency30,870 4.65%(26,366)4.14%
Ending balance$12,615,399 4.06%$12,231,595 3.69%
The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 
 Three Months Ended
 March 31, 2023March 31, 2022
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$2,129,954 4.33%$2,202,312 3.03%
Debt issued362,900 4.97%5,385 3.08%
Debt assumed53,223 3.62% %
Debt extinguished(24,631)4.53%(100,821)4.21%
Principal payments(14,942)3.91%(15,968)3.19%
Foreign currency304 4.39%24,733 2.73%
Ending balance$2,506,808 4.55%$2,115,641 3.02%
Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2023, we were in compliance in all material respects with all of the covenants under our debt agreements. 
12. Derivative Instruments
We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contracts, interest rate swaps, interest rate locks and debt issued in foreign currencies to offset a portion of these risks.

15

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Cash Flow Hedges and Fair Value Hedges of Interest Rate Risk
We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt.
Interest rate swaps designated as fair value hedges involve the receipt of fixed amounts from a counterparty in exchange for our variable-rate payments. These interest rate swap agreements hedge the exposure to changes in the fair value of fixed-rate debt attributable to changes in the designated benchmark interest rate. For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative instrument, as well as the offsetting loss or gain on the hedged item attributable to the hedged risk, are recognized in earnings. We record the gain or loss on the hedged items in interest expense, the same line item as the offsetting loss or gain on the related interest rate swaps. In March 2022, we entered into a $550,000,000 fixed to floating swap in connection with our March senior note issuance. The carrying amount of the notes, exclusive of the hedge, is $545,504,000. The fair value of the swap as of March 31, 2023 was ($40,829,000) and was recorded as a derivative liability with an offset to senior unsecured notes on our Consolidated Balance Sheets.
Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into earnings over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately recognized in the Consolidated Statements of Comprehensive Income. Approximately $2,562,000 of losses, which are included in other comprehensive income ("OCI"), are expected to be reclassified into earnings in the next 12 months.
Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges
We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.
During the three months ended March 31, 2023 and 2022, we settled certain net investment hedges generating cash proceeds of $1,994,000 and $10,169,000, respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.
Derivative Contracts Undesignated
We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.
Equity Warrants
We received equity warrants through our lending activities, which were accounted for as loan origination fees. The warrants provide us the right to participate in the capital appreciation of the underlying HC-One Group real estate portfolio above a designated price upon liquidation and contain net settlement terms qualifying as derivatives under ASC Topic 815. The warrants are classified within receivables and other assets on our Consolidated Balance Sheets. These warrants are measured at fair value with changes in fair value being recognized within gain (loss) on derivatives and financial instruments in our Consolidated Statements of Comprehensive Income.










16

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 
 March 31, 2023December 31, 2022
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$1,075,000 $1,075,000 
Denominated in Pound Sterling£1,890,708 £1,890,708 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$250,000 $250,000 
Denominated in Pound Sterling£1,050,000 £1,050,000 
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)
$375,000 $25,000 
Interest rate swaps designated as fair value hedges:
Denominated in U.S Dollars$550,000 $550,000 
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars$26,137 $26,137 
Foreign currency exchange contracts denominated in Canadian Dollars$80,000 $80,000 
(1) At March 31, 2023 the maximum maturity date was March 31, 2024.
The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):
Three Months Ended March 31,
DescriptionLocation20232022
Gain (loss) on derivative instruments designated as hedges recognized in incomeInterest expense$4,619 $5,984 
Gain (loss) on derivative instruments not designated as hedges recognized in incomeInterest expense$(254)$(693)
Gain (loss) on equity warrants recognized in incomeGain (loss) on derivatives and financial instruments$(885)$(2,423)
Gain (loss) on derivative and financial instruments designated as hedges recognized in OCIOCI$(69,738)$51,940 
13. Commitments and Contingencies
At March 31, 2023, we had 22 outstanding letter of credit obligations totaling $51,447,000 and expiring between 2023 and 2024. At March 31, 2023, we had outstanding construction in progress of $1,121,446,000 and committed to providing additional funds of approximately $2,057,726,000 to complete construction. Additionally, at March 31, 2023, we had outstanding investments classified as in substance real estate of $713,342,000 and committed to provide additional funds of $140,641,000 (see Note 8 for additional information). Purchase obligations also include $38,729,000 of contingent purchase obligations to fund capital improvements. Rents due from the tenants are increased to reflect the additional investment in the property.
14. Stockholders’ Equity 
The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 
 March 31, 2023December 31, 2022
Preferred Stock, $1.00 par value:
Authorized shares50,000,000 50,000,000 
Issued shares  
Outstanding shares  
Common Stock, $1.00 par value:
Authorized shares700,000,000 700,000,000 
Issued shares498,095,420 492,283,488 
Outstanding shares496,294,516 490,508,937 
17

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Common Stock In April 2022, we entered into an amended and restated equity distribution agreement whereby we can offer and sell up to $3,000,000,000 aggregate amount of our common stock ("ATM Program"). The ATM Program also allows us to enter into forward sale agreements (none outstanding at March 31, 2023). As of March 31, 2023, we had $737,046,000 of remaining capacity under the ATM Program.
The following is a summary of our common stock issuances during the three months ended March 31, 2023 and 2022 (dollars in thousands, except shares and average price amounts): 
 Shares IssuedAverage PriceGross ProceedsNet Proceeds
2022 Option exercises299 $66.89 $20 $20 
2022 ATM Program issuances6,605,191 84.60 558,790 549,326 
2022 Stock incentive plans, net of forfeitures103,079 — — 
2022 Totals6,708,569 $558,810 $549,346 
2023 ATM Program issuances5,603,161 $73.74 $413,157 $411,032 
2023 Redemption of OP Units and DownREIT Units
271,997 — — 
2023 Stock incentive plans, net of forfeitures(89,579)— — 
2023 Totals5,785,579 $413,157 $411,032 
Dividends The following is a summary of our dividend payments (in thousands, except per share amounts): 
 Three Months Ended
 March 31, 2023March 31, 2022
Per ShareAmountPer ShareAmount
Common stock$0.61 $301,829 $0.61 $273,668 
Accumulated Other Comprehensive Income The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):
March 31, 2023December 31, 2022
Foreign currency translation$(1,037,431)$(1,115,317)
Derivative and financial instruments designated as hedges925,872 995,610 
Total accumulated other comprehensive income (loss)$(111,559)$(119,707)
15. Stock Incentive Plans
In March 2022, our Board of Directors approved the 2022 Long-Term Incentive Plan ("2022 Plan"), which authorizes up to 10,000,000 shares of common stock or units to be issued at the discretion of the Compensation Committee of the Board of Directors. Awards granted after March 28, 2022 will be issued out of the 2022 Plan. The awards granted under the 2016 Long-Term Incentive Plan continue to vest and options expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2022 Plan. The 2022 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock units, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted stock units generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $9,456,000 and $7,445,000 for the three months ended March 31, 2023 and 2022, respectively.












18

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
16. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended March 31,
 20232022
Numerator for basic earnings per share - net income (loss) attributable to common stockholders
$25,673 $61,925 
Adjustment for net income (loss) attributable to OP Units and DownREIT Units(10)(145)
Numerator for diluted earnings per share
$25,663 $61,780 
Denominator for basic earnings per share - weighted average shares492,061 447,379 
Effect of dilutive securities:
Employee stock options
4 31 
Non-vested restricted shares and units613 974 
OP Units and DownREIT Units
1,786 1,396 
Employee stock purchase program
30 22 
Dilutive potential common shares2,433 2,423 
Denominator for diluted earnings per share - adjusted weighted average shares
494,494 449,802 
Basic earnings per share$0.05 $0.14 
Diluted earnings per share$0.05 $0.14 
As of March 31, 2022, outstanding forward sales agreements for the sale of 14,297,958 shares were not included in the computation of diluted earnings per share because such forward sales were anti-dilutive for the period. There were no outstanding forward sales agreements as of March 31, 2023.
17. Disclosure about Fair Value of Financial Instruments 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-level valuation hierarchy exists for disclosures of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 for additional information. The three levels are defined below: 
Level 1 - Quoted prices in active markets for identical assets or liabilities. 
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.                                         
Mortgage Loans, Other Real Estate Loans and Non-real Estate Loans Receivable — The fair value of mortgage loans, other real estate loans and non-real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.
Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 
Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices. 
Equity Warrants The fair value of equity warrants is estimated using Level 3 inputs and includes data points such as enterprise value of the underlying HC-One Group real estate portfolio, marketability discount for private company warrants, dividend yield, volatility and risk-free rate. The enterprise value is driven by projected cash flows, weighted average cost of capital and a terminal capitalization rate.
19

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Borrowings Under Primary Unsecured Credit Facility and Commercial Paper Program — The carrying amount of the primary unsecured credit facility and commercial paper program approximates fair value because the borrowings are interest rate adjustable. 
Senior Unsecured Notes — The fair value of the senior unsecured notes payable is estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 
Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 
Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates.
Redeemable DownREIT Unitholder Interests — Our redeemable DownREIT Unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs unless the fair value is below the initial amount, in which case the redeemable DownREIT Unitholder interests are recorded at the initial amount adjusted for distributions to the unitholders and income or loss attributable to the unitholders. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
 March 31, 2023December 31, 2022
 Carrying AmountFair ValueCarrying AmountFair Value
Financial assets:
Mortgage loans receivable$718,961 $759,712 $697,906 $739,159 
Other real estate loans receivable235,195 235,573 192,938 190,977 
Equity securities66 66 111 111 
Cash and cash equivalents571,902 571,902 631,681 631,681 
Restricted cash66,894 66,894 90,611 90,611 
Non-real estate loans receivable297,513 285,404 289,168 277,601 
Foreign currency forward contracts, interest rate swaps and cross currency swaps148,206148,206 191,357 191,357 
Equity warrants30,269 30,269 30,436 30,436 
Financial liabilities:
Senior unsecured notes$12,486,229 $11,629,220 $12,437,273 $11,381,873 
Secured debt2,474,837 2,451,673 2,110,815 2,054,889 
Foreign currency forward contracts, interest rate swaps and cross currency swaps40,829 40,829 55,727 55,727 
Redeemable DownREIT Unitholder interests$61,957 $61,957 $75,355 $75,355 
Items Measured at Fair Value on a Recurring Basis 
The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):
 Fair Value Measurements as of March 31, 2023
 TotalLevel 1Level 2Level 3
Equity securities$66 $66 $ $ 
Equity warrants30,269   30,269 
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
107,377  107,377  
Totals $137,712 $66 $107,377 $30,269 
(1) Please see Note 12 for additional information.



20

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the change in fair value for equity warrants using unobservable Level 3 inputs for the periods presented (in thousands):
Three Months Ended
 March 31, 2023March 31, 2022
Beginning balance$30,436 $41,909 
Mark-to-market adjustment(885)(2,425)
Foreign currency718 (1,068)
Ending balance$30,269 $38,416 
The most significant assumptions utilized in the valuation of the equity warrants are the cash flows of the underlying HC-One Group enterprise, as well as the terminal capitalization rate of 10.5%.
Items Measured at Fair Value on a Nonrecurring Basis 
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis that are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired or assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date. 
18. Segment Reporting
We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our Seniors Housing Operating properties include seniors apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Our Triple-net properties include the property types described above as well as long-term/post-acute care facilities. Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our Outpatient Medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.
We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.  
Non-segment revenue consists mainly of interest income on cash investments recorded in other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. All inter-segment transactions are eliminated.
21

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 
Three Months Ended March 31, 2023:Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$1,131,685 $ $ $ $1,131,685 
Rental income 202,419 181,640  384,059 
Interest income2,551 33,763 91  36,405 
Other income2,445 1,883 3,100 1,152 8,580 
Total revenues1,136,681 238,065 184,831 1,152 1,560,729 
Property operating expenses883,784 11,723 58,365 3,881 957,753 
Consolidated net operating income (loss)252,897 226,342 126,466 (2,729)602,976 
Depreciation and amortization220,407 54,528 64,177  339,112 
Interest expense11,487 (15)4,104 128,827 144,403 
General and administrative expenses   44,371 44,371 
Loss (gain) on derivatives and financial instruments, net 930   930 
Loss (gain) on extinguishment of debt, net  5  5 
Provision for loan losses, net(73)850   777 
Impairment of assets12,629    12,629 
Other expenses17,579 2,467 547 2,152 22,745 
Income (loss) from continuing operations before income taxes and other items(9,132)167,582 57,633 (178,079)38,004 
Income tax (expense) benefit   (3,045)(3,045)
Income (loss) from unconsolidated entities(15,589)8,432 86  (7,071)
Gain (loss) on real estate dispositions, net833 520 (606) 747 
Income (loss) from continuing operations(23,888)176,534 57,113 (181,124)28,635 
Net income (loss)$(23,888)$176,534 $57,113 $(181,124)$28,635 
Total assets$22,201,219 $8,776,956 $7,007,092 $508,622 $38,493,889 
Three Months Ended March 31, 2022:Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$994,335 $ $ $ $994,335 
Rental income 196,001 160,389  356,390 
Interest income1,417 37,506 71  38,994 
Other income860 1,656 2,863 606 5,985 
Total revenues996,612 235,163 163,323 606 1,395,704 
Property operating expenses789,928 11,211 49,915 2,615 853,669 
Consolidated net operating income (loss)206,684 223,952 113,408 (2,009)542,035 
Depreciation and amortization192,793 53,504 57,791  304,088 
Interest expense7,650 314 4,567 109,165 121,696 
General and administrative expenses   37,706 37,706 
Loss (gain) on derivatives and financial instruments, net 2,578   2,578 
Loss (gain) on extinguishment of debt, net(15) 3  (12)
Provision for loan losses, net267 (1,065)(6) (804)
Other expenses8,191 11,044 

789 6,045 26,069 
Income (loss) from continuing operations before income taxes and other items(2,202)157,577 50,264 (154,925)50,714 
Income tax (expense) benefit   (5,013)(5,013)
Income (loss) from unconsolidated entities(17,782)15,543 (645) (2,884)
Gain (loss) on real estate dispositions, net2,701 20,449 (216) 22,934 
Income (loss) from continuing operations(17,283)193,569 49,403 (159,938)65,751 
Net income (loss)$(17,283)$193,569 $49,403 $(159,938)$65,751 


22

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 
 Three Months Ended
 March 31, 2023March 31, 2022
Revenues:Amount%Amount%
United States$1,296,022 83.0 %$1,139,016 81.6 %
United Kingdom147,876 9.5 %144,491 10.4 %
Canada116,831 7.5 %112,197 8.0 %
Total$1,560,729 100.0 %$1,395,704 100.0 %
Three Months Ended
March 31, 2023March 31, 2022
Resident Fees and Services:Amount%Amount%
United States$908,944 80.4 %$784,097 78.8 %
United Kingdom109,012 9.6 %101,090 10.2 %
Canada113,729 10.0 %109,148 11.0 %
Total$1,131,685 100.0 %$994,335 100.0 %
 As of
 March 31, 2023December 31, 2022
Assets:Amount%Amount%
United States$32,325,218 84.0 %$31,740,907 83.8 %
United Kingdom3,518,034 9.1 %3,476,793 9.2 %
Canada2,650,637 6.9 %2,675,533 7.0 %
Total$38,493,889 100.0 %$37,893,233 100.0 %
19. Income Taxes and Distributions 
We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 
Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 
Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the three months ended March 31, 2023 and 2022, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. Subsequent to 2014 we transferred certain subsidiaries to the United Kingdom, while some wholly-owned direct and
23

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
indirect subsidiaries remain in Luxembourg and Jersey. The company reflects current and deferred tax liabilities for any such withholding taxes incurred from this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the foreign, federal, state and local taxing authorities under applicable local laws.
20. Variable Interest Entities 
We have entered into joint ventures and have certain subsidiaries that are wholly owned by consolidated joint ventures and own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the entities and the rights to receive residual returns or the obligation to absorb losses arising from the entities. Except for capital contributions associated with the initial entity formations, the entities have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such entities have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):
March 31, 2023December 31, 2022
Assets:
Net real estate investments$1,492,518 $1,499,078 
Cash and cash equivalents11,577 15,582 
Receivables and other assets32,582 9,949 
Total assets (1)
$1,536,677 $1,524,609 
Liabilities and equity:
Secured debt$155,678 $155,992 
Lease liabilities1,329 1,329 
Accrued expenses and other liabilities39,119 28,417 
Total equity1,340,551 1,338,871 
Total liabilities and equity$1,536,677 $1,524,609 
(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.
24

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
EXECUTIVE SUMMARY
   
Company Overview
Business Strategy
Key Transactions
 Key Performance Indicators, Trends and Uncertainties
Corporate Governance
 LIQUIDITY AND CAPITAL RESOURCES
   
Sources and Uses of Cash
Off-Balance Sheet Arrangements
Contractual Obligations
Capital Structure
Supplemental Guarantor Information
   
 RESULTS OF OPERATIONS
   
Summary
Seniors Housing Operating
Triple-net
Outpatient Medical
Non-Segment/Corporate
   
 OTHER
   
 Non-GAAP Financial Measures
 Critical Accounting Policies and Estimates
 Cautionary Statement Regarding Forward-Looking Statements
25

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read together with the Consolidated Financial Statements and related Notes thereto included in Item 1 of this report. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2022, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations."
On March 7, 2022, we announced our intent to complete an UPREIT reorganization. In February 2022, the company formerly known as Welltower Inc. ("Old Welltower") formed WELL Merger Holdco Inc. ("New Welltower") as a wholly owned subsidiary, and New Welltower formed WELL Merger Holdco Sub Inc. ("Merger Sub") as a wholly owned subsidiary. On April 1, 2022, Merger Sub merged with and into Old Welltower, with Old Welltower continuing as the surviving corporation and a wholly owned subsidiary of New Welltower (the "Merger"). In connection with the Merger, Old Welltower's name was changed to "Welltower OP Inc.", and New Welltower inherited the name "Welltower Inc." Effective May 24, 2022, Welltower OP Inc. ("Welltower OP") converted from a Delaware corporation into a Delaware limited liability company named Welltower OP LLC (the "LLC Conversion"). Following the LLC Conversion, New Welltower's business continues to be conducted through Welltower OP and New Welltower does not have substantial assets or liabilities, other than through its investment in Welltower OP.
Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP.
Executive Summary
Company Overview
Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower owns interests in properties concentrated in major, high-growth markets in the United States ("U.S."), Canada and the United Kingdom ("U.K."), consisting of seniors housing and post-acute communities and outpatient medical properties.
Welltower is the initial member and majority owner of Welltower OP, with an approximate ownership interest of 99.721% as of March 31, 2023. All of our property ownership, development and related business operations are conducted through Welltower OP and Welltower has no material assets or liabilities other than its investment in Welltower OP. Welltower issues equity from time to time, the net proceeds of which it is obligated to contribute as additional capital to Welltower OP. All debt including credit facilities, senior notes and secured debt is incurred by Welltower OP, and Welltower has fully and unconditionally guaranteed all existing senior unsecured notes.
The following table summarizes our consolidated portfolio for the three months ended March 31, 2023 (dollars in thousands):
  Percentage ofNumber of
Type of Property
NOI (1)
NOIProperties
Seniors Housing Operating$252,897 41.7 %854 
Triple-net226,342 37.4 %575 
Outpatient Medical126,466 20.9 %356 
Totals$605,705 100.0 %1,785 
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See "Non-GAAP Financial Measures" below for additional information and reconciliation.
Business Strategy
Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.
Substantially all of our revenues are derived from operating lease rentals, resident fees and services and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Additionally, the extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence.

26

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs and market conditions among other things. We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.
In addition to our asset management and research efforts, we also aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guarantees and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.
For the three months ended March 31, 2023, resident fees and services and rental income represented 73% and 25%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.
We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and commercial paper program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and commercial paper program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.
Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and commercial paper program. At March 31, 2023, we had $571,902,000 of cash and cash equivalents, $66,894,000 of restricted cash and $4,000,000,000 of available borrowing capacity under our unsecured revolving credit facility.
Key Transactions
Capital The following summarizes key capital transactions that occurred during the three months ended March 31, 2023:
During the three months ended March 31, 2023, we, sold 5,603,161 shares of common stock under our ATM Program generating gross proceeds of approximately $413,157,000.
During the three months ended March 31, 2023, we issued $362,900,000 of secured debt at a blended average interest rate of 4.97% and assumed $53,223,000 of secured debt at a blended average interest rate of 3.62%. We extinguished $24,631,000 of secured debt at a blended average interest rate of 4.53%.
Investments The following summarizes our property acquisitions and joint venture investments completed during the three months ended March 31, 2023 (dollars in thousands): 
27

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Properties
Book Amount (1)
Capitalization Rates (2)
Seniors Housing Operating2$19,816 7.5 %
Triple-net81,659 3.6 %
Outpatient Medical29 356,250 6.9 %
Totals39 $457,725 6.9 %
(1) Represents amounts recorded in net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.
(2) Represents annualized contractual or projected net operating income to be received in cash divided by investment amounts.
Dispositions The following summarizes property dispositions completed during the three months ended March 31, 2023 (dollars in thousands): 
 Properties
Proceeds (1)
Book Amount (2)
Capitalization Rates (3)
Seniors Housing Operating1$19,054 $18,572 — %
Triple-net12,604 2,028 — %
Totals$21,658 $20,600 — %
(1) Represents net proceeds received upon disposition, including any seller financing.
(2) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
(3) Represents annualized contractual income that was being received in cash at date of disposition divided by stated purchase price. Excludes properties sold that were recent development conversions.
Dividends Our Board of Directors declared a cash dividend for the quarter ended March 31, 2023 of $0.61 per share. On May 23, 2023, we will pay our 208th consecutive quarterly cash dividend to stockholders of record on May 16, 2023.
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, credit strength and concentration risk. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
Operating Performance We believe that net income and net income attributable to common stockholders (“NICS”) per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”) and consolidated net operating income (“NOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations. These earnings measures are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies.
The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands):
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20232022202220222022
Net income (loss)$28,635 $1,798 $(2,653)$95,672 $65,751 
NICS25,673 (3,728)(6,767)89,785 61,925 
FFO386,062 357,985 362,863 409,589 347,635 
NOI602,976 579,693 561,664 618,453 542,035 
Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and restricted cash. The coverage ratios indicate our ability to service interest and fixed charges (interest and secured debt principal amortization). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliation of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented: 
28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20232022202220222022
Net debt to book capitalization ratio40%39%42%43%43%
Net debt to undepreciated book capitalization ratio32%32%34%35%35%
Net debt to market capitalization ratio28%30%32%27%24%
Interest coverage ratio3.44x3.29x3.48x4.21x4.03x
Fixed charge coverage ratio3.13x3.01x3.18x3.78x3.57x
Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or international equivalents).
The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below: 
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20232022202220222022
Property mix:(1)
   
Seniors Housing Operating42%40%41%45%38%
Triple-net37%38%38%36%41%
Outpatient Medical21%22%21%19%21%
Relationship mix: (1)
Integra Healthcare Properties(2)
9%1%—%—%—%
Sunrise Senior Living6%7%7%8%6%
Cogir Management Corporation4%4%4%3%2%
StoryPoint Senior Living4%3%4%3%4%
HC-One Group3%3%4%4%4%
Remaining relationships74%82%81%82%84%
Geographic mix:(1)
California13%14%13%15%13%
United Kingdom10%9%10%9%11%
Texas8%8%8%7%8%
Pennsylvania6%5%5%4%5%
Canada6%6%6%5%5%
Remaining geographic areas57%58%58%60%58%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) In December 2022, we transitioned 147 skilled nursing facilities previously leased to ProMedica, to master leases with Integra Healthcare Properties.












29

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of March 31, 2023 (dollars in thousands):
 
Expiration Year (1)
 2023202420252026202720282029203020312032Thereafter
Triple-net:          
Properties15 49 34 88 347 
Base rent (2)
$2,159 $13,088 $7,083 $45,392 $1,182 $5,246 $4,091 $69,215 $10,701 $65,614 $401,905 
% of base rent0.3 %2.1 %1.1 %7.3 %0.2 %0.8 %0.7 %11.1 %1.7 %10.5 %64.2 %
Units/beds270 692 451 3,404 80 440 219 3,669 423 4,314 37,490 
% of Units/beds0.5 %1.3 %0.9 %6.6 %0.2 %0.9 %0.4 %7.1 %0.8 %8.4 %72.9 %
Outpatient Medical:          
Square feet1,902,520 1,982,088 1,403,780 1,576,623 1,461,893 1,190,865 1,111,637 1,297,190 1,628,893 1,241,483 3,854,522 
Base rent (2)
$53,714 $60,111 $41,175 $42,708 $40,941 $32,221 $31,244 $34,996 $44,430 $37,110 $107,250 
% of base rent10.2 %11.4 %7.8 %8.1 %7.8 %6.1 %5.9 %6.7 %8.4 %7.1 %20.5 %
Leases415 346 259 239 218 180 105 96 65 131 466 
% of Leases16.5 %13.7 %10.3 %9.5 %8.7 %7.1 %4.2 %3.8 %2.6 %5.2 %18.4 %
(1) Excludes our share of investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved, and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2022, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Corporate Governance
Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.
Liquidity and Capital Resources
Sources and Uses of Cash
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. 





30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our sources and uses of cash flows for the periods presented (dollars in thousands):
 Three Months EndedChange
March 31, 2023March 31, 2022$%
Cash, cash equivalents and restricted cash at beginning of period$722,292 $346,755 $375,537 108 %
Cash provided from (used in) operating activities376,058 324,520 51,538 16 %
Cash provided from (used in) investing activities(932,837)(808,547)(124,290)(15)%
Cash provided from (used in) financing activities470,470 505,105 (34,635)(7)%
Effect of foreign currency translation2,813 (790)3,603 456 %
Cash, cash equivalents and restricted cash at end of period$638,796 $367,043 $271,753 74 %
Operating Activities Please see “Results of Operations” for discussion of net income fluctuations. For the three months ended March 31, 2023 and 2022, cash flows provided from operations exceeded cash distributions to stockholders. 
Investing Activities The changes in net cash provided from/used in investing activities are primarily attributable to net changes in real property investments and dispositions, loans receivable and investments in unconsolidated entities, which are summarized above in "Key Transactions." Please refer to Notes 3 and 5 of our unaudited consolidated financial statements for additional information. The following is a summary of cash used in non-acquisition capital improvement activities for the periods presented (dollars in thousands): 
 Three Months EndedChange
 March 31, 2023March 31, 2022$%
New development$226,226 $138,141 $88,085 64 %
Recurring capital expenditures, tenant improvements and lease commissions36,914 32,835 4,079 12 %
Renovations, redevelopments and other capital improvements54,425 57,394 (2,969)(5)%
Total$317,565 $228,370 $89,195 39 %
The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization.
Financing Activities The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuances of common stock and dividend payments which are summarized above in "Key Transactions." Please refer to Notes 10, 11 and 14 of our unaudited consolidated financial statements for additional information.
In March 2022, we completed the issuance of $550,000,000 senior unsecured notes with a maturity date of June 2032. In April 2022, we closed on an amended $5,200,000,000 unsecured credit facility, increasing our term loan capacity by $500,000,000. During the three months ended March 31, 2023, we issued $362,900,000 of secured debt at a blended average interest rate of 4.97% and assumed $53,223,000 of secured debt at a blended average interest rate of 3.62%. As of March 31, 2023, we have total near-term available liquidity of approximately $4.6 billion.
Off-Balance Sheet Arrangements 
At March 31, 2023, we had investments in unconsolidated entities with our ownership generally ranging from 10% to 88%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At March 31, 2023, we had 22 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.






31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Contractual Obligations
The following table summarizes our payment requirements under contractual obligations as of March 31, 2023 (in thousands):
 Payments Due by Period
Contractual ObligationsTotal20232024-20252026-2027Thereafter
Senior unsecured notes and term credit facilities: (1)
U.S. Dollar senior unsecured notes$9,900,000 $— $2,600,000 $1,200,000 $6,100,000 
Canadian Dollar senior unsecured notes (2)
221,811 — — 221,811 — 
Pounds Sterling senior unsecured notes (2)
1,298,745 — — — 1,298,745 
U.S. Dollar term credit facility1,010,000 — 10,000 1,000,000 — 
Canadian Dollar term credit facility (2)
184,843 — — 184,843 — 
Secured debt: (1,2)
Consolidated2,506,808 550,304 663,823 326,319 966,362 
Unconsolidated1,318,901 235,171 700,068 185,821 197,841 
Contractual interest obligations: (3)
Senior unsecured notes and term loans (2)
3,918,263 482,474 914,524 717,563 1,803,702 
Consolidated secured debt (2)
518,918 80,378 155,596 110,274 172,670 
Unconsolidated secured debt (2)
170,369 40,821 60,850 22,842 45,856 
Financing lease liabilities (4)
206,650 70,014 5,632 3,606 127,398 
Operating lease liabilities (4)
959,766 15,277 35,707 31,403 877,379 
Purchase obligations (5)
2,252,308 1,228,576 955,820 67,912 — 
Total contractual obligations$24,467,382 $2,703,015 $6,102,020 $4,072,394 $11,589,953 
(1) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Based on foreign currency exchange rates in effect as of the balance sheet date.
(3) Based on variable interest rates in effect as of the balance sheet date.
(4) See Note 6 to our unaudited consolidated financial statements for additional information.
(5) See Note 13 to our unaudited consolidated financial statements for additional information.
Capital Structure
Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2023, we were in compliance in all material respects with the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
On April 1, 2022, Welltower and Welltower OP jointly filed with the Securities and Exchange Commission (the “SEC”) an open-ended automatic or “universal” shelf registration statement on Form S-3 covering an indeterminate amount of future offerings of Welltower’s debt securities, common stock, preferred stock, depositary shares, guarantees of debt securities issued by Welltower OP, warrants and units and Welltower OP’s debt securities and guarantees of debt securities issued by Welltower to replace Old Welltower’s existing “universal” shelf registration statement filed with the SEC on May 4, 2021. On April 1, 2022, Welltower also filed with the SEC a registration statement in connection with its enhanced dividend reinvestment plan (“DRIP”) under which it may issue up to 15,000,000 shares of common stock to replace Old Welltower’s existing DRIP registration statement on Form S-3 filed with the SEC on May 4, 2021. As of April 28, 2023, 15,000,000 shares of common stock remained available for issuance under the DRIP registration statement. On April 4, 2022, Welltower and Welltower OP entered into (i) a second amended and restated equity distribution agreement (the “EDA”) with (i) Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BOK Financial Securities, Inc., Capital One Securities Inc., Citigroup Global Markets Inc., Comerica Securities, Inc., Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, Jefferies LLC, JMP Securities LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Loop Capital Markets LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., Synovus Securities, Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as sales agents and forward
32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
sellers and (ii) the forward purchasers named therein relating to issuances, offers and sales from time to time of up to $3,000,000,000 aggregate amount of common stock of Welltower (together with the existing master forward sale confirmations relating thereto, the “ATM Program”), amending and restating the ATM Program entered into on July 30, 2021 to, among other amendments, increase the total amount of shares of common stock that may be offered and sold under the ATM Program from $2,500,000,000 to $3,000,000,000, which amount excludes shares Old Welltower had previously sold pursuant to the prior program. The ATM Program also allows Welltower to enter into forward sale agreements. As of April 28, 2023, we had $682,342,278 of remaining capacity under the ATM Program and there were no outstanding forward sales agreements. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and commercial paper program.
In connection with the filing of the new “universal” shelf registration statement, Welltower also filed with the SEC two prospectus supplements that will continue offerings that were previously covered by Old Welltower's prospectus supplements and the accompanying prospectus to the prior registration statement relating to: (i) the registration of up to 620,731 shares of common stock of Welltower (the “DownREIT Shares”), that may be issued from time to time if, and to the extent that, certain holders of Class A units (the “DownREIT Units”) of HCN G&L DownREIT, LLC, a Delaware limited liability company (the “DownREIT”), tender such DownREIT Units for redemption by the DownREIT, and HCN DownREIT Member, LLC, a majority-owned indirect subsidiary of Welltower (including its permitted successors and assigns, the “Managing Member”), or a designated affiliate of the Managing Member, elects to assume the redemption obligations of the DownREIT and to satisfy all or a portion of the redemption consideration by issuing DownREIT Shares to the holders instead of or in addition to paying a cash amount; and (ii) the registration of up to 475,327 shares of common stock of Welltower Inc. (the “DownREIT II Shares”), that may be issued from time to time if, and to the extent that, certain holders of Class A units (the “DownREIT II Units,” and collectively with the DownREIT Units, the “Units”) of HCN G&L DownREIT II LLC, a Delaware limited liability company (the “DownREIT II”), tender such DownREIT II Units for redemption by the DownREIT II, and the Managing Member, or a designated affiliate of the Managing Member, elects to assume the redemption obligations of the DownREIT II and to satisfy all or a portion of the redemption consideration by issuing DownREIT II Shares to the holders instead of or in addition to paying a cash amount. On July 22, 2022, Welltower filed with the SEC a prospectus supplement relating to the registration of up to 300,026 shares of common stock of Welltower Inc. that may be issued from time to time if, and to the extent that, certain holders of Class A Common Units (the "OP Units") of Welltower OP tender the OP Units for redemption by Welltower OP, and Welltower Inc. elects to assume the redemption obligations of Welltower OP and to satisfy all or a portion of the redemption consideration by issuing shares of its common stock to the holders instead of or in addition to paying a cash amount.
Supplemental Guarantor Information
Welltower OP has issued the unsecured notes described in Note 11 to our Consolidated Financial Statements. All unsecured notes are fully and unconditionally guaranteed by Welltower, and Welltower OP is 99.721% owned by Welltower as of March 31, 2023. Effective January 4, 2021, the SEC adopted amendments to the financial disclosure requirements applicable to registered debt offerings that include certain credit enhancements. The Company has adopted these new rules, which permits subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. Accordingly, separate consolidated financial statements of Welltower OP have not been presented. Furthermore, Welltower and Welltower OP have no material assets, liabilities, or operations other than financing activities and their investments in non-guarantor subsidiaries. Therefore, we meet the criteria in Rule 13-01 of Regulation S-X to omit the summarized financial information from our disclosures.
Results of Operations
Summary
Our primary sources of revenue include resident fees and services, rent and interest income. Our primary expenses include property operating expenses, depreciation and amortization, interest expense, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and same store NOI ("SSNOI"), and other supplemental measures include Funds From Operations ("FFO") and EBITDA, which are further discussed below. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations. The following is a summary of our results of operations (dollars in thousands, except per share amounts):
33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months EndedChange
 March 31,March 31,
 20232022Amount%
Net income (loss)$28,635 $65,751 $(37,116)(56)%
NICS25,673 61,925 (36,252)(59)%
FFO386,062 347,635 38,427 11 %
EBITDA515,195 496,548 18,647 %
NOI602,976 542,035 60,941 11 %
SSNOI439,449 402,216 37,233 %
Per share data (fully diluted):
NICS$0.05 $0.14 $(0.09)(64)%
FFO$0.78 $0.77 $0.01 %
Interest coverage ratio3.44 x4.03 x(0.59)x(15)%
Fixed charge coverage ratio3.13 x3.57 x(0.44)x(12)%
Seniors Housing Operating
The following is a summary of our results of operations for the Seniors Housing Operating segment (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,
 20232022$%
Revenues:
Resident fees and services$1,131,685 $994,335 $137,350 14 %
Interest income2,551 1,417 1,134 80 %
Other income2,445 860 1,585 184 %
Total revenues1,136,681 996,612 140,069 14 %
Property operating expenses883,784 789,928 93,856 12 %
NOI (1)
252,897 206,684 46,213 22 %
Other expenses:
Depreciation and amortization220,407 192,793 27,614 14 %
Interest expense11,487 7,650 3,837 50 %
Loss (gain) on extinguishment of debt, net— (15)15 100 %
Provision for loan losses, net(73)267 (340)(127)%
Impairment of assets12,629 — 12,629 n/a
Other expenses17,579 8,191 9,388 115 %
262,029 208,886 53,143 25 %
Income (loss) from continuing operations before income taxes and other items(9,132)(2,202)(6,930)(315)%
Income (loss) from unconsolidated entities(15,589)(17,782)2,193 12 %
Gain (loss) on real estate dispositions, net833 2,701 (1,868)(69)%
Income from continuing operations(23,888)(17,283)(6,605)(38)%
Net income (loss)(23,888)(17,283)(6,605)(38)%
Less: Net income (loss) attributable to noncontrolling interests(3,317)(5,381)2,064 38 %
Net income (loss) attributable to common stockholders$(20,571)$(11,902)$(8,669)(73)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Resident fees and services and property operating expenses increased for the three month periods ended March 31, 2023 compared to the same period in the prior year primarily due to acquisitions outpacing dispositions during 2022 and year to date 2023. Additionally, our Seniors Housing Operating revenues are dependent on occupancy and rate growth, both of which have continued to increase since the same period in the prior year. Average occupancy is as follows:
Three Months Ended(1)
 March 31,June 30,September 30,December 31,
202276.3 %77.1 %78.0 %78.3 %
202379.0 %
(1) Average occupancy includes our minority ownership share related to unconsolidated properties and excludes the minority partners' noncontrolling ownership share related to consolidated properties. Also excludes land parcels and properties under development.

34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our SSNOI at Welltower's share for the Seniors Housing Operating segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2023March 31, 2022$%
SSNOI (1)
$211,306 $177,089 $34,217 19.3 %
(1) For the QTD Pool, amounts relate to 746 same store properties. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
During the three months ended March 31, 2023, we recorded impairment charges of $12,252,000 related to three held for sale properties for which the carrying values exceeded the estimated fair value less costs to sell and $377,000 related to one held for use property for which the carrying value exceeded the estimated fair value. No impairment was recorded during the same period in 2022. Transaction costs related to asset acquisitions are capitalized as a component of the purchase price. The fluctuation in other expenses is primarily due to the timing of noncapitalizable transaction costs associated with acquisitions and operator transitions. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
Depreciation and amortization fluctuates as a result of acquisitions, dispositions and transitions. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 
During the three months ended March 31, 2023, we completed one conversion representing $26,711,667 or $193,563 per unit. The following is a summary of our Seniors Housing Operating construction projects in process, excluding expansions (dollars in thousands):
As of March 31, 2023
Expected Conversion Year(1)
PropertiesUnits/BedsAnticipated Remaining FundingConstruction in Progress Balance
202391,216 $67,110 $272,677 
2024152,439 529,421 404,803 
20252665 124,569 27,936 
TBD(2)
11106,173 
Total37$811,589 
(1) Properties expected to be converted in phases over multiple years are reflected in the last expected year.
(2) Represents projects for which a final budget or expected conversion date are not yet known.
Interest expense represents secured debt interest expense, which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The fluctuations in loss (gain) on extinguishment of debt is primarily attributable to the volume of extinguishments and terms of the related secured debt. The following is a summary of our Seniors Housing Operating segment property secured debt principal activity (dollars in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$1,701,939 4.32 %$1,599,522 2.81 %
Debt transferred— — %32,478 4.79 %
Debt issued362,900 4.97 %5,385 3.08 %
Debt assumed6,482 4.21 %— — %
Debt extinguished— — %(94,647)4.21 %
Principal payments(13,007)3.86 %(12,998)2.92 %
Foreign currency304 4.39 %24,733 2.73 %
Ending balance$2,058,618 4.58 %$1,554,473 2.83 %
Monthly averages$1,822,546 4.44 %$1,606,723 2.84 %
35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The majority of our Seniors Housing Operating properties are formed through partnership interests. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures.
Triple-net
The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,
 20232022$%
Revenues:
Rental income$202,419 $196,001 $6,418 %
Interest income33,763 37,506 (3,743)(10)%
Other income1,883 1,656 227 14 %
Total revenues238,065 235,163 2,902 %
Property operating expenses11,723 11,211 512 %
NOI (1)
226,342 223,952 2,390 %
Other expenses: 
Depreciation and amortization54,528 53,504 1,024 %
Interest expense(15)314 (329)(105)%
Loss (gain) on derivatives and financial instruments, net930 2,578 (1,648)(64)%
Provision for loan losses, net850 (1,065)1,915 180 %
Other expenses2,467 11,044 (8,577)(78)%
58,760 66,375 (7,615)(11)%
Income (loss) from continuing operations before income taxes and other items167,582 157,577 10,005 %
Income (loss) from unconsolidated entities8,432 15,543 (7,111)(46)%
Gain (loss) on real estate dispositions, net520 20,449 (19,929)(97)%
Income from continuing operations176,534 193,569 (17,035)(9)%
Net income176,534 193,569 (17,035)(9)%
Less: Net income (loss) attributable to noncontrolling interests5,903 7,065 (1,162)(16)%
Net income attributable to common stockholders$170,631 $186,504 $(15,873)(9)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the three months ended March 31, 2023, we had 23 leases with rental rate increases ranging from 0.58% to 43.39% in our Triple-net portfolio.
The following is a summary of our SSNOI at Welltower's share for the Triple-net segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2023March 31, 2022$%
SSNOI (1)
$117,716 $116,780 $936 0.8 %
(1) For the QTD Pool, amounts relate to 415 same store properties. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
Depreciation and amortization fluctuates as a result of the acquisitions, dispositions and segment transitions of Triple-net properties. To the extent we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 
Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the three months ended March 31, 2023, there were no Triple-net construction projects completed. The following is a summary of our consolidated Triple-net construction projects in process, excluding expansions (dollars in thousands): 
As of March 31, 2023
Expected Conversion YearPropertiesUnits/BedsAnticipated Remaining FundingConstruction in Progress Balance
20231191$32,701 $121,441 
During the three months ended March 31, 2022, loss (gain) on derivatives and financial instruments, net is primarily attributable to the mark-to-market of the equity warrants received as part of the Safanad/HC-One transaction that closed in the second quarter of 2021. In addition, the mark-to-market adjustment on our Genesis HealthCare available-for-sale investment is reflected in all periods.
Interest expense represents secured debt interest expense and related fees. The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Triple-net secured debt principal activity for the periods presented (dollars in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$39,179 4.39 %$72,536 4.57 %
Debt transferred— — %(32,478)4.79 %
Principal payments(230)4.37 %(221)4.37 %
Ending balance$38,949 4.39 %$39,837 4.39 %
Monthly averages$39,029 4.39 %$39,914 4.39 %
A portion of our Triple-net properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. The decrease in income from unconsolidated entities is primarily related to the restructure of an unconsolidated joint venture into a consolidated structure. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner.














37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Outpatient Medical
The following is a summary of our results of operations for the Outpatient Medical segment for the periods presented (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,
 20232022$%
Revenues:
Rental income$181,640 $160,389 $21,251 13 %
Interest income91 71 20 28 %
Other income3,100 2,863 237 %
Total revenues184,831 163,323 21,508 13 %
Property operating expenses58,365 49,915 8,450 17 %
NOI (1)
126,466 113,408 13,058 12 %
Other expenses: 
Depreciation and amortization64,177 57,791 6,386 11 %
Interest expense4,104 4,567 (463)(10)%
Loss (gain) on extinguishment of debt, net67 %
Provision for loan losses, net— (6)100 %
Other expenses547 789 (242)(31)%
68,833 63,144 5,689 %
Income (loss) from continuing operations before income taxes and other items57,633 50,264 7,369 15 %
Income (loss) from unconsolidated entities86 (645)731 113 %
Gain (loss) on real estate dispositions, net(606)(216)(390)(181)%
Income from continuing operations57,113 49,403 7,710 16 %
Net income (loss)57,113 49,403 7,710 16 %
Less: Net income (loss) attributable to noncontrolling interests682 2,142 (1,460)(68)%
Net income (loss) attributable to common stockholders$56,431 $47,261 $9,170 19 %
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Rental income has increased due primarily to acquisitions and construction conversions that occurred during 2022 and the year to date in 2023. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the three months ended March 31, 2023, our consolidated outpatient medical portfolio signed 80,010 square feet of new leases and 539,121 square feet of renewals. The weighted-average term of these leases was seven years, with a rate of $32.21 per square foot and tenant improvement and lease commission costs of $13.81 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 1.0% to 9.0%. 
The fluctuations in property operating expenses and depreciation and amortization are primarily attributable to acquisitions and construction conversions that occurred during 2022 and year to date in 2023. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly.
The following is a summary of our SSNOI at Welltower's share for the Outpatient Medical segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2023March 31, 2022$%
SSNOI (1)
$110,423 $108,347 $2,076 1.9 %
(1) For the QTD Pool, amounts relate to 371 same store properties. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
During the three months ended March 31, 2023, we completed one conversion representing $9,351,000 or $555 per square foot. The following is a summary of the consolidated Outpatient Medical construction projects in process, excluding expansions (dollars in thousands):
38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
As of March 31, 2023
Expected Conversion YearPropertiesSquare FeetAnticipated Remaining FundingConstruction in Progress Balance
20233228,276 $88,881 $39,856 
20242211,368 118,010 22,478 
TBD(1)
236,679 
Total7$99,013 
(1) Represents projects for which a final budget or expected conversion date are not yet known.
Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our Outpatient Medical secured debt principal activity (dollars in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$388,836 4.38 %$530,254 3.49 %
Debt assumed46,741 3.54 %— — %
Debt extinguished(24,631)4.53 %(6,174)4.17 %
Principal payments(1,705)4.27 %(2,749)4.38 %
Ending balance$409,241 4.43 %$521,331 3.51 %
Monthly averages$409,860 4.41 %$526,392 3.49 %
A portion of our Outpatient Medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner.
Non-Segment/Corporate
The following is a summary of our results of operations for the Non-Segment/Corporate activities for the periods presented (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,
 20232022$%
Revenues:
Other income$1,152 $606 $546 90 %
Total revenues1,152 606 546 90 %
Property operating expenses3,881 2,615 1,266 48 %
NOI (1)
(2,729)(2,009)(720)(36)%
Expenses:
Interest expense128,827 109,165 19,662 18 %
General and administrative expenses44,371 37,706 6,665 18 %
Other expenses2,152 6,045 (3,893)(64)%
175,350 152,916 22,434 15 %
Loss from continuing operations before income taxes and other items(178,079)(154,925)(23,154)(15)%
Income tax benefit (expense)(3,045)(5,013)1,968 39 %
Loss from continuing operations(181,124)(159,938)(21,186)(13)%
Net loss attributable to common stockholders$(181,124)$(159,938)$(21,186)(13)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Property operating expenses represent insurance costs related to our captive insurance company, which acts as a direct insurer of property level insurance coverage for our portfolio.


39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our Non-Segment/Corporate interest expense for the periods presented (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,  
 20232022$%
Senior unsecured notes$120,814 $101,239 $19,575 19 %
Unsecured credit facility and commercial paper program2,406 2,779 (373)(13)%
Loan expense5,607 5,147 460 %
Totals$128,827 $109,165 $19,662 18 %
The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement in foreign exchange rates and related hedge activity. Please refer to Note 11 for additional information. The change in interest expense on our unsecured revolving credit facility and commercial paper program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 for additional information regarding our unsecured revolving credit facility and commercial paper program. Loan expenses represent the amortization of costs incurred in connection with senior unsecured notes issuances.
General and administrative expenses as a percentage of consolidated revenues for the three months ended March 31, 2023 and 2022 were 2.84% and 2.70%, respectively. The provision for income taxes primarily relates to state taxes, foreign taxes and taxes based on income generated by entities that are structured as TRSs.
Other
Non-GAAP Financial Measures
We believe that net income and net income attributable to common stockholders, as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.
NOI is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent general overhead costs that are unrelated to property operations and unallocable to the properties. These expenses include, but are not limited to, payroll and benefits related to corporate employees, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. We believe the drivers of property level NOI for both consolidated properties and unconsolidated properties are generally the same and therefore, we evaluate SSNOI based on our ownership interest in each property ("Welltower Share"). To arrive at Welltower's Share, NOI is adjusted by adding our minority ownership share related to unconsolidated properties and by subtracting the minority partners' noncontrolling ownership interests for consolidated properties. We do not control investments in unconsolidated properties and while we consider disclosures at Welltower Share to be useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in SSNOI five full quarters after acquisition or being placed into service for the QTD Pool. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the respective periods are excluded from SSNOI. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties undergoing a change in intended use) are excluded from SSNOI until five full quarters post completion of the redevelopment for the QTD Pool. Properties undergoing operator transitions and/or segment transitions are also excluded from SSNOI until five full quarters post completion of the transition for the QTD Pool. In addition, properties significantly impacted by force majeure, acts of God, or other extraordinary adverse events are excluded from SSNOI until five full quarters after the properties are placed back into service for the QTD Pool.
40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
SSNOI excludes non-cash NOI and includes adjustments to present consistent ownership percentages and to translate Canadian properties and U.K. properties using a consistent exchange rate. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.
EBITDA is defined as earnings (net income) before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding unconsolidated entities and including adjustments for stock-based compensation expense, provision for loan losses, gains/losses on extinguishment of debt, gains/loss/impairments on properties, gains/losses on derivatives and financial instruments, other expenses, other impairment charges and other adjustments as deemed appropriate. We believe that EBITDA and Adjusted EBITDA, along with net income, are important supplemental measures because they provide additional information to assess and evaluate the performance of our operations. We primarily use these measures to determine our interest coverage ratio, which represents EBITDA and Adjusted EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA and Adjusted EBITDA divided by fixed charges. Fixed charges include total interest and secured debt principal amortization. Covenants in our unsecured senior notes and primary credit facility contain financial ratios based on a definition of EBITDA and Adjusted EBITDA that is specific to those agreements. Our leverage ratios are defined as the proportion of net debt to total capitalization and include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock.
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization, gains/loss on real estate dispositions and impairment of assets. Amounts are in thousands except for per share data.
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
FFO Reconciliation:20232022202220222022
Net income (loss) attributable to common stockholders$25,673 $(3,728)$(6,767)$89,785 $61,925 
Depreciation and amortization339,112 342,286 353,699 310,295 304,088 
Impairment of assets12,629 13,146 4,356 — — 
Loss (gain) on real estate dispositions, net(747)4,423 (1,064)3,532 (22,934)
Noncontrolling interests(13,327)(13,989)(14,614)(13,173)(14,753)
Unconsolidated entities22,722 15,847 27,253 19,150 19,309 
FFO$386,062 $357,985 $362,863 $409,589 $347,635 
Average diluted shares outstanding
For net income (loss) purposes494,494 483,305 463,366 457,082 449,802 
For FFO purposes494,494 486,419 466,950 457,082 449,802 
Per diluted share data:   
Net income attributable to common stockholders(1)
$0.05 $(0.01)$(0.01)$0.20 $0.14 
FFO$0.78 $0.74 $0.78 $0.90 $0.77 
(1) Includes adjustment to the numerator for income (loss) attributable to OP Unitholders.


41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of consolidated NOI to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollar amounts are in thousands.
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
NOI Reconciliations:20232022202220222022
Net income (loss)$28,635 $1,798 $(2,653)$95,672 $65,751 
Loss (gain) on real estate dispositions, net(747)4,423 (1,064)3,532 (22,934)
Loss (income) from unconsolidated entities7,071 4,650 6,698 7,058 2,884 
Income tax expense (benefit)3,045 (4,088)3,257 3,065 5,013 
Other expenses22,745 24,954 15,481 35,166 26,069 
Impairment of assets12,629 13,146 4,356 — — 
Provision for loan losses, net777 10,469 490 165 (804)
Loss (gain) on extinguishment of debt, net87 603 (12)
Loss (gain) on derivatives and financial instruments, net930 258 6,905 (1,407)2,578 
General and administrative expenses44,371 41,319 34,811 36,554 37,706 
Depreciation and amortization339,112 342,286 353,699 310,295 304,088 
Interest expense144,403 140,391 139,682 127,750 121,696 
Consolidated net operating income (NOI)$602,976 $579,693 $561,664 $618,453 $542,035 
NOI by segment:   
Seniors Housing Operating$252,897 $234,091 $230,686 $281,911 $206,684 
Triple-net226,342 222,879 217,324 222,869 223,952 
Outpatient Medical126,466 124,421 119,257 115,674 113,408 
Non-segment/corporate(2,729)(1,698)(5,603)(2,001)(2,009)
Total NOI$602,976 $579,693 $561,664 $618,453 $542,035 


The following is a reconciliation of the properties included in our QTD Pool for SSNOI:
QTD Pool
SSNOI Property Reconciliations:Seniors Housing OperatingTriple-netOutpatient MedicalTotal
Consolidated properties
854 575 356 1,785 
Unconsolidated properties
105 39 79 223 
Total properties
959 614 435 2,008 
Recent acquisitions/development conversions(1)
(98)(13)(44)(155)
Under development
(41)— (6)(47)
Under redevelopment(2)
(9)(6)(4)(19)
Current held for sale
(5)(7)(1)(13)
Land parcels, loans and subleases
(21)(8)(9)(38)
Transitions(3)
(29)(163)— (192)
Other(4)
(10)(2)— (12)
Same store properties
746 415 371 1,532 
(1) Acquisitions and development conversions will enter the QTD Pool five full quarters after acquisition or certificate of occupancy.
(2) Redevelopment properties will enter the QTD Pool five full quarters of operations post redevelopment completion.
(3) Transitioned properties will enter the QTD Pool after five full quarters of operations with the new operator in place or under the new structure.
(4) Represents properties that are either closed or being closed.









42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a reconciliation of our consolidated NOI to same store NOI for the periods presented for the respective pools. Dollar amounts are in thousands.
QTD Pool
Three Months Ended
SSNOI Reconciliations:March 31, 2023March 31, 2022
Seniors Housing Operating:
 
Consolidated NOI
$252,897 $206,684 
NOI attributable to unconsolidated investments
12,126 12,751 
NOI attributable to noncontrolling interests
(16,260)(24,392)
NOI attributable to non-same store properties
(35,634)(12,519)
Non-cash NOI attributable to same store properties
(1,301)(1,865)
Currency and ownership adjustments (1)
(522)(3,570)
SSNOI at Welltower Share211,306 177,089 
Triple-net:
Consolidated NOI
226,342 223,952 
NOI attributable to unconsolidated investments
9,293 9,955 
NOI attributable to noncontrolling interests
(7,608)(15,338)
NOI attributable to non-same store properties
(95,978)(91,430)
Non-cash NOI attributable to same store properties
(14,099)(8,567)
Currency and ownership adjustments (1)
(234)(1,792)
SSNOI at Welltower Share117,716 116,780 
Outpatient Medical:
Consolidated NOI
126,466 113,408 
NOI attributable to unconsolidated investments
4,935 4,830 
NOI attributable to noncontrolling interests
(5,188)(5,240)
NOI attributable to non-same store properties
(11,676)(1,989)
Non-cash NOI attributable to same store properties
(4,294)(3,237)
Currency and ownership adjustments (1)
180 575 
SSNOI at Welltower Share110,423 108,347 
SSNOI at Welltower Share:
Seniors Housing Operating211,306 177,089 
Triple-net117,716 116,780 
Outpatient Medical110,423 108,347 
Total$439,445 $402,216 
(1) Includes adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.37 and to translate U.K. properties at a GBP/USD rate of 1.20.


















43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The tables below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
EBITDA Reconciliations:20232022202220222022
Net income (loss)$28,635 $1,798 $(2,653)$95,672 $65,751 
Interest expense144,403 140,391 139,682 127,750 121,696 
Income tax expense (benefit)3,045 (4,088)3,257 3,065 5,013 
Depreciation and amortization339,112 342,286 353,699 310,295 304,088 
EBITDA$515,195 $480,387 $493,985 $536,782 $496,548 
Interest Coverage Ratio:   
Interest expense$144,403 $140,391 $139,682 $127,750 $121,696 
Non-cash interest expense(5,083)(4,280)(6,759)(6,606)(4,109)
Capitalized interest10,335 9,762 8,863 6,387 5,479 
Total interest
149,655 145,873 141,786 127,531 123,066 
EBITDA$515,195 $480,387 $493,985 $536,782 $496,548 
Interest coverage ratio
3.44 x3.29 x3.48 x4.21 x4.03 x
Fixed Charge Coverage Ratio:   
Total interest$149,655 $145,873 $141,786 $127,531 $123,066 
Secured debt principal payments14,942 13,989 13,775 14,382 15,968 
Total fixed charges
164,597 159,862 155,561 141,913 139,034 
EBITDA$515,195 $480,387 $493,985 $536,782 $496,548 
Fixed charge coverage ratio
3.13 x3.01 x3.18 x3.78 x3.57 x























44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
 Twelve Months Ended
March 31,December 31,September 30,June 30,March 31,
Adjusted EBITDA Reconciliations:20232022202220222022
Net income$123,452 $160,568 $224,964 $417,953 $368,038 
Interest expense552,226 529,519 510,976 493,816 488,407 
Income tax expense (benefit)5,279 7,247 13,386 15,069 9,783 
Depreciation and amortization1,345,392 1,310,368 1,252,583 1,166,638 1,097,228 
EBITDA
2,026,349 2,007,702 2,001,909 2,093,476 1,963,456 
Loss (income) from unconsolidated entities25,477 21,290 28,814 37,948 38,866 
Stock-based compensation expense27,709 26,027 22,402 20,766 18,994 
Loss (gain) on extinguishment of debt, net697 680 (497)(504)54,505 
Loss (gain) on real estate dispositions, net6,144 (16,043)(32,139)(151,029)(199,229)
Impairment of assets30,131 17,502 6,713 3,847 27,539 
Provision for loan losses, net11,098 10,320 (188)(949)5,083 
Loss (gain) on derivatives and financial instruments, net5,751 8,334 7,246 (7,737)(6,689)
Other expenses98,346 101,670 92,199 80,293 56,814 
Lease termination and leasehold interest adjustment (1)
(56,397)(64,854)(63,454)(64,094)(7,697)
Casualty losses, net of recoveries14,865 10,391 7,802 8,472 5,799 
Other impairment (2)
(620)(620)(620)(620)— 
Adjusted EBITDA$2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted Interest Coverage Ratio:   
Interest expense$552,226 $529,519 $510,976 $493,816 $488,407 
Capitalized interest35,347 30,491 26,054 21,860 20,335 
Non-cash interest expense(22,728)(21,754)(18,679)(21,258)(18,624)
Total interest
564,845 538,256 518,351 494,418 490,118 
Adjusted EBITDA$2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted interest coverage ratio
3.88 x3.94 x3.99 x4.09 x3.99 x
Adjusted Fixed Charge Coverage Ratio:
Total interest$564,845 $538,256 $518,351 $494,418 $490,118 
Secured debt principal payments57,088 58,114 61,002 64,267 65,600 
Total fixed charges
621,933 596,370 579,353 558,685 555,718 
Adjusted EBITDA$2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted fixed charge coverage ratio
3.52 x3.56 x3.57 x3.62 x3.52 x
(1) Represents revenues and property operating expenses associated with a leasehold portfolio interest relating to 26 properties assumed by a wholly-owned affiliate in conjunction with the Holiday Retirement transaction. Subsequent to the initial transaction, we purchased eight of the leased properties and one of the properties was sold by the landlord and removed from the lease. No rent was paid in excess of net cash flow relating to the leasehold properties and therefore, the net impact has been excluded from Adjusted EBITDA. Additionally, in conjunction with the lease termination, during the three months ended June 30, 2022 we recognized $58,621,000 in other income from the derecognition of the right of use asset and related lease liability which has also been excluded from Adjusted EBITDA.
(2) Represents changes in the reserve for straight-line rent receivable balances relating to leases placed on cash recognition.

Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization.






45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price. 
As of
 March 31,December 31,September 30,June 30,March 31,
 20232022202220222022
Book capitalization:   
Unsecured credit facility and commercial paper$$$654,715$354,000$299,968
Long-term debt obligations (1)
15,074,32014,661,55214,555,64314,790,43214,352,529
Cash and cash equivalents and restricted cash
(638,796)(722,292)(425,184)(442,251)(367,043)
Total net debt14,435,52413,939,26014,785,17414,702,18114,285,454
Total equity and noncontrolling interests(2)
21,596,15521,393,99620,457,65019,873,91319,178,026
Book capitalization$36,031,679$35,333,256$35,242,824$34,576,094$33,463,480
Net debt to book capitalization ratio
40%39%42%43%43%
Undepreciated book capitalization:   
Total net debt$14,435,524$13,939,260$14,785,174$14,702,181$14,285,454
Accumulated depreciation and amortization8,417,1518,075,7337,687,0777,437,7797,215,622
Total equity and noncontrolling interests(2)
21,596,15521,393,99620,457,65019,873,91319,178,026
Undepreciated book capitalization$44,448,830$43,408,989$42,929,901$42,013,873$40,679,102
Net debt to undepreciated book capitalization ratio32%32%34%35%35%
Market capitalization:   
Common shares outstanding496,295490,509472,517463,369453,948
Period end share price$71.69$65.55$64.32$82.35$96.14
Common equity market capitalization$35,579,389$32,152,865$30,392,293$38,158,437$43,642,561
Total net debt14,435,52413,939,26014,785,17414,702,18114,285,454
Noncontrolling interests(2)
1,148,0001,099,1821,288,3431,317,7331,282,450
Market capitalization$51,162,913$47,191,307$46,465,810$54,178,351$59,210,465
Net debt to market capitalization ratio
28%30%32%27%24%
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheets. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests as reflected on our Consolidated Balance Sheets.
Critical Accounting Policies and Estimates
Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
the impact of the estimates and assumptions on financial condition or operating performance is material.
Management has discussed the development and selection of its critical accounting policies and estimates with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 for further information on significant accounting policies that impact us. There have been no material changes to these policies in 2023.
46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “pro forma,” “estimate” or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause Welltower’s actual results to differ materially from Welltower’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the impact of the COVID-19 pandemic; the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting Welltower’s properties; Welltower’s ability to re-lease space at similar rates as vacancies occur; Welltower’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower’s properties; changes in rules or practices governing Welltower’s financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower’s ability to maintain its qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower’s reports filed from time to time with the SEC. Other important factors are identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, Welltower undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.
We historically borrow on our unsecured revolving credit facility and commercial paper program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and commercial paper program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.
A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments after considering the effects of interest rate swaps, whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):
47

Item 3. Quantitative and Qualitative Disclosures About Market Risk
 March 31, 2023December 31, 2022
 PrincipalChange inPrincipalChange in
 balancefair valuebalancefair value
Senior unsecured notes$11,220,556 $(493,154)$10,839,782 $(488,159)
Secured debt1,813,095 (63,568)1,448,567 (36,654)
Totals$13,033,651 $(556,722)$12,288,349 $(524,813)
Our variable rate debt, including our unsecured revolving credit facility and commercial paper program, is reflected at fair value. At March 31, 2023, we had $2,088,556,000 outstanding related to our variable rate debt after considering the effects of interest rate swaps. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $20,886,000. At December 31, 2022, we had $2,426,134,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $24,261,000. 
We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or British Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended March 31, 2023, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our annualized net income from these investments would increase or decrease, as applicable, by less than $7,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or British Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):
 March 31, 2023December 31, 2022
 CarryingChange inCarryingChange in
 Valuefair valueValuefair value
Foreign currency exchange contracts$146,527 $14,694 $190,418 $14,238 
Debt designated as hedges1,483,588 14,836 1,452,832 14,528 
Totals$1,630,115 $29,530 $1,643,250 $28,766 
For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 12 and 17 to our unaudited consolidated financial statements.
Item 4. Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

48


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition. It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.
Item 1A. Risk Factors
There have been no material changes from the risk factors identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended March 31, 2023, we acquired shares of our common stock held by employees who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from employees and the average prices paid per share for each month in the first quarter ended March 31, 2023 are as shown in the table below.
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Repurchase ProgramMaximum Dollar Value of Shares that May Yet Be Purchased Under the Repurchase Program
January 1, 2023 through January 31, 202316,646 $71.15 — $3,000,000,000 
February 1, 2023 through February 28, 20237,369 76.17 — 3,000,000,000 
March 1, 2023 through March 31, 20232,338 76.17 — 3,000,000,000 
Totals26,353 $73.00 — $3,000,000,000 
On November 7, 2022, our Board of Directors approved a share repurchase program for up to $3,000,000,000 of common stock (the "Stock Repurchase Program"). Under the Stock Repurchase Program, we are not required to purchase shares but may choose to do so in the open market or through privately-negotiated transactions, through block trades, by effecting a tender offer, by way of an accelerated share repurchase program, through the purchase of call options or the sale of put options, or otherwise, or by any combination of the foregoing. We expect to finance any share repurchases using available cash and may use proceeds from borrowings or debt offerings. The Stock Repurchase Program has no expiration date and does not obligate us to repurchase any specific number of shares. We did not repurchase any shares of our common stock through the Stock Repurchase Program during the three months ended March 31, 2023.
Item 5. Other Information 
None.

49


Item 6. Exhibits
10.1
10.2
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL
*Management contract or Compensatory Plan or Arrangement.





















50


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the under signed thereunto duly authorized.

 
WELLTOWER INC.
  
 
Date:May 3, 2023By:  /s/ SHANKH MITRA 
 Shankh Mitra,  
 Chief Executive Officer
 (Principal Executive Officer) 
 
 
   
Date:May 3, 2023By:  /s/ TIMOTHY G. MCHUGH 
 Timothy G. McHugh,  
 Executive Vice President and Chief Financial Officer
 (Principal Financial Officer) 
 
 
   
Date:May 3, 2023By:  /s/ JOSHUA T. FIEWEGER 
 Joshua T. Fieweger,  
 Chief Accounting Officer
 (Principal Accounting Officer) 
 
51